Since market valuations are always changing, along with outlooks for corporate revenue and earnings, any list of favored stocks is only a snapshot. Repeating the same analysis in the near term might l
Recently, Zacks.com users have been paying close attention to Hologic (HOLX). This makes it worthwhile to examine what the stock has in store.
U.S. equities rallied Friday to post solid gains, with the S&P 500 adding 1.6% and the Nasdaq soaring 2%. The market powered ahead as bond yields pulled back from their jump Thursday when Fed Chair Je
Steve MacMillan, Hologic CFO, joins 'Squawk on the Street' to discuss key tailwinds Hologic is seeing, strategic use cases for the company's cash, and playbooks for weight-loss drugs.
U.S. equities gained at midday after yesterday's selloff snapped long winning streaks for the S&P 500 and Nasdaq. Bond yields were lower after jumping yesterday when Fed Chair Jerome Powell suggested
Hologic, Inc. (NASDAQ:HOLX ) Q4 2023 Earnings Call Transcript November 9, 2023 4:30 PM ET Company Participants Ryan Simon - Vice President, Investor Relations Stephen MacMillan - Chairman, President a
While the top- and bottom-line numbers for Hologic (HOLX) give a sense of how the business performed in the quarter ended September 2023, it could be worth looking at how some of its key metrics compa

Hologic fourth-quarter sales beat estimates

06:24pm, Thursday, 09'th Nov 2023
Hologic on Thursday reported fourth-quarter sales that beat Wall Street estimates on strong demand in its breast health segment, sending the medtech firm's shares up 2.7% in extended trading.
Besides Wall Street's top -and-bottom-line estimates for Hologic (HOLX), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the qu
Hologic (HOLX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Strength in Breast Health and growing Panther instrument installed base will likely benefit Hologic's (HOLX) Q4 performance.
In the most recent trading session, Hologic (HOLX) closed at $67.56, indicating a -0.37% shift from the previous trading day.
Hologic (HOLX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
In the latest trading session, Hologic (HOLX) closed at $69.22, marking a +0.35% move from the previous day.
Hologic's (HOLX) collaboration with AAGL and Inovus Medical is likely to optimize OB-GYN training for minimally invasive surgeries.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE